Efficacy of rosuvastatin 10 mg in patients with the metabolic syndrome

American Journal of Cardiology

Volumn 91, Issue 5 SUPPL. 1, 2003, Pages 25-27

  Ballantyne, Christie M ^a,f   Stein, Evan A ^b,c   Paoletti, Rodolfo ^d   Southworth, Harry ^e   Blasetto, James W ^e   Barter, Philip ^g   Rader, Daniel J ^g  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b Metabolic and Atherosclerosis Research Center   (United States)

^c Pharmaceutical Product Development   (United States)

^d UNIVERSITY OF MILAN   (Italy)

^e ASTRAZENECA   (United Kingdom)

^f HOUSTON METHODIST RESEARCH INSTITUTE   (United States)

^g MS A601 ^*

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN A1; APOLIPOPROTEIN B; GLUCOSE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; ROSUVASTATIN; TRIACYLGLYCEROL;

ADULT; BODY MASS; CHOLESTEROL BLOOD LEVEL; CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; FEMALE; GLUCOSE BLOOD LEVEL; GLYCEROL BLOOD LEVEL; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; METABOLIC DISORDER; METABOLIC SYNDROME X; MULTICENTER STUDY; PRIORITY JOURNAL;

EID: 0037422068     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9149(03)00006-7     Document Type: Conference Paper

References (0)